id: delayed_diagnosis_aald_to_advanced_aald_presentation
name: Delayed Diagnosis of AALD â†’ Advanced Stage AALD at Presentation
from_node:
  node_id: delayed_diagnosis_aald
  node_name: Delayed Diagnosis of AALD
to_node:
  node_id: advanced_aald_presentation
  node_name: Advanced Stage AALD at Presentation
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Lack of early screening and noninvasive testing prevents identification
  of early-stage AALD'
- 'Step 2: Absence of red flag recognition (low albumin, low platelet count, raised
  transaminases) allows silent disease progression'
- 'Step 3: Patients present only when symptomatic with advanced fibrosis or cirrhosis'
- 'Step 4: Late-stage presentation results in higher morbidity and mortality due to
  limited treatment options'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Saggere Muralikrishna Shasthry and Shiv Kumar Sarin 2024. "Alcohol-Associated
    Liver Diseases: Spectrum, Nomenclature, and Definitions.." *Clinics in liver disease*.
    https://doi.org/10.1016/j.cld.2024.06.003'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.392197'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: healthcare_access
  direction: weakens
  strength: strong
  description: Access to algorithmic approaches using noninvasive tests can enable
    early diagnosis and prevent progression to advanced disease
- name: availability_noninvasive_testing
  direction: weakens
  strength: strong
  description: Availability of enhanced liver fibrosis score, elastography, and fibrosis-4
    scores enables earlier detection before advanced stages
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/delayed_diagnosis_aald_to_advanced_aald_presentation.yaml
_category: healthcare_access
